WP
FBRX icon

Woodline Partners’s Forte Biosciences FBRX Stock Holding History

Woodline Partners’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Buy
712,753
+380,766
+115% +$9.03M 0.05% 440
2026
Q1 		$8.6M Hold
331,987
– – 0.03% 549
2025
Q4 		$9.05M Hold
331,987
– – 0.04% 483
2025
Q3 		$4.98M Hold
331,987
– – 0.02% 570
2025
Q2 		$4.29M Buy
331,987
+127,165
+62% +$1.09M 0.02% 591
2025
Q1 		$1.59M Buy
204,822
+547
+0.3% +$6.46K 0.01% 703
2024
Q4 		$4.64M Buy
+204,275
New +$2.43M 0.03% 498
2021
Q4 		– Sell
-5,724
Closed -$424K – 730
2021
Q3 		$424K Sell
5,724
-2,023
-26% -$1.12M 0.01% 556
2021
Q2 		$6.51M Buy
7,747
+134
+2% +$121K 0.12% 193
2021
Q1 		$6.52M Sell
7,613
-78
-1% -$63.9K 0.14% 169
2020
Q4 		$7M Buy
+7,691
New +$7.23M 0.19% 139

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Woodline Partners's FBRX Position: Q2 2026 in Review

Woodline Partners increased its Forte Biosciences (FBRX) stake by 115% in Q2 2026, buying an estimated $9.03M and bringing the position to 712,753 shares worth $15.1M. The position accounts for 0.05% of the portfolio, ranked #440.

Woodline Partners first reported a position in FBRX in Q4 2020 and has held it in 11 quarters since. 56 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Woodline Partners held 712,753 shares of Forte Biosciences worth $15.1M as of Q2 2026.
  • Woodline Partners bought 380,766 Forte Biosciences shares in Q2 2026, an estimated $9.03M.
  • Forte Biosciences made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #440 holding.
  • Woodline Partners first reported a position in Forte Biosciences in Q4 2020 and has held it in 11 quarters since.
  • 56 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.